Spyre Therapeutics Inc

The current institutional shareholding score of Spyre Therapeutics Inc is 10.00, ranking 1 out of 389 in the Biotechnology & Medical Research industry. The latest institutional shareholding proportion is 103.37%, representing a quarter-over-quarter increase of 19.72%. The largest institutional shareholder is ETHSX, holding a total of 13.79K shares, representing 0.03% of shares outstanding, with 200.00% increase in holdings.